Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018Jonathan M. Loree, Kanwal Raghav, Gauri Varadhachary et al.|JAMA Oncology|2019Cited by 568
Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical CompaniesJoseph M. Unger, Kanwal Raghav, Dawn L. Hershman et al.|JNCI Cancer Spectrum|2020Cited by 113
Interferon Alfa Consolidation After Intensive Chemotherapy Does Not Prolong the Progression-Free Survival of Patients With Low-Grade Non-Hodgkin’s Lymphoma: Results of the Southwest Oncology Group Randomized Phase III Study 8809Richard I. Fisher, Thomas P. Miller, Vivek Roy et al.|Journal of Clinical Oncology|2000Cited by 81